Affordable Access

deepdyve-link
Publisher Website

Omega-3 fatty acid supplementation affects pregnancy outcomes in gestational diabetes: a randomized, double-blind, placebo-controlled trial.

Authors
  • Jamilian, Mehri1
  • Samimi, Mansooreh2
  • Kolahdooz, Fariba3
  • Khalaji, Farzaneh4
  • Razavi, Maryamalsadat5
  • Asemi, Zatollah4
  • 1 a Department of Gynecology and Obstetrics , School of Medicine, Arak University of Medical Sciences , Arak , Iran . , (Iran)
  • 2 b Department of Gynecology and Obstetrics , School of Medicine, Kashan University of Medical Sciences , Kashan , I.R. Iran . , (Iran)
  • 3 c Aboriginal and Global Health Research Group, Department of Medicine, Faculty of Medicines and Dentistry , University of Alberta , Edmonton , Canada . , (Canada)
  • 4 d Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences , Kashan , I.R. Iran , and. , (Iran)
  • 5 e Department of Gynecology and Obstetrics , School of Medicine, Ardabil University of Medical Sciences , Ardabil , I.R. Iran. , (Iran)
Type
Published Article
Journal
The Journal of Maternal-Fetal & Neonatal Medicine
Publisher
Informa UK (Taylor & Francis)
Publication Date
Jan 01, 2016
Volume
29
Issue
4
Pages
669–675
Identifiers
DOI: 10.3109/14767058.2015.1015980
PMID: 25747955
Source
Medline
Keywords
License
Unknown

Abstract

Taken together, omega-3 fatty acid supplementation in GDM women had beneficial effects on maternal serum hs-CRP, plasma MDA levels, incidence of newborn's hyperbilirubinemia, and hospitalization.

Report this publication

Statistics

Seen <100 times